Kristina Sonnevi

Publikationer
CV
Populärvetenskap och samverkan

Utvalda publikationer

Journal article: THE LANCET. 2024;403(10441):2293-2306
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Dreyling M; Doorduijn J; Gine E; Jerkeman M; Walewski J; Hutchings M; Mey U; Riise J; Trneny M; Vergote V; Shpilberg O; da Silva MG; Leppa S; Jiang L; Stilgenbauer S; Kerkhoff A; Jachimowicz R; Celli M; Hess G; Arcaini L; Visco C; van Meerten T; Wirths S; Zinzani PL; Novak U; Herhaus P; Benedetti F; Sonnevi K; Hanoun C; Haenel M; Dierlamm J; Pott C; Klapper W; Goezel D; Schmidt C; Unterhalt M; Ladetto M; Hoster E
Article: LEUKEMIA AND LYMPHOMA. 2024;65(4):534-537
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Harrysson S; Eloranta S; Ekberg S; Enblad G; Andersson P-O; Sonnevi K; Ljungqvist M; Sander B; Jerkeman M; Smedby KE
Article: LEUKEMIA. 2024;38(2):610-620
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
Ren W; Wan H; Abd Own S; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini R-M; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarstrom Q
Article: BLOOD ADVANCES. 2024;8(2):407-415
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial
Jerkeman M; Kolstad A; Hutchings M; Pasanen A; Meriranta L; Niemann CU; Jorgensen RRK; El-Galaly TC; Riise J; Leppa S; Christensen JH; Sonnevi K; Pedersen LB; Wader KF; Glimelius I

Artiklar

Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(16_suppl):7015
EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL.
Vose J; Vitolo U; Lugtenburg P; Chamuleau MED; Linton KM; Thieblemont C; Sonnevi K; Jurczak W; Olszewski AJ; Awan FT; Okada CY; Feldman TA; Hutchings M; Favaro E; Hoehn D; Li Z; Conlon R; Sancho J-M; Chavez JC
Article: EJHAEM. 2023;4(3):647-655
Splenic marginal zone lymphoma in Sweden 2000-2020: Increasing rituximab use and better survival in the elderly
Junlen H-R; Sonnevi K; Linden O; Hellstrom M; Scivetti MV; Olsson M; Tufvesson I; Johansson A-S; Wahlin BE
Article: HEMASPHERE. 2023;7(8):e928
Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project
Jerkeman M; Ekberg S; Glimelius I; Albertsson-Lindblad A; Entrop JP; Ellin F; Sonnevi K; Lewerin C; Brandefors L; Smedby KE
Article: ISCIENCE. 2023;26(6):106864
ADAR1-mediated RNA editing promotes B cell lymphomagenesis
Pecori R; Ren W; Pirmoradian M; Binder M; Papavasiliou N; Wang X; Liu D; Berglund M; Li W; Tasakis RN; Di Giorgio S; Ye X; Li X; Wu K; Helm D; Arnold A; Wust S; Schneider M; Selvasaravanan K-D; Fuell Y; Stafforst T; Amini R-M; Sonnevi K; Enblad G; Sander B; Wahlin BE; Zhang H; Papavasiliou FN; Pan-Hammarstrom Q
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):476-477
How to choose between curative radiotherapy or chemotherapy in low stage MCL?—a population‐based analysis of outcome in patients with stage I‐II MCL in Sweden
Albertsson‐Lindblad A; Ekberg S; Glimelius I; Ellin F; Sonnevi K; Lewerin C; Smedby KE; Jerkeman M
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:429-430
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
Smedby KE; Antonilli S; Enblad G; Sonnevi K; Wahlin BE; Andersson P; Jerkeman M; Eloranta S
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:302-303
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
Ren W; Own SA; Wan H; Berglund M; Wang X; Yang M; Li X; Liu D; Sonnevi K; Enblad G; Amini R; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarström Q
Article: CANCERS. 2023;15(5):1585
2-Arachidonoylglycerol Modulates CXCL12-Mediated Chemotaxis in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
Merrien M; Wasik AM; Melen CM; Morsy MHA; Sonnevi K; Junlen H-R; Christensson B; Wahlin BE; Sander B
Article: FRONTIERS IN ONCOLOGY. 2023;13:1176698
Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study
Haider Z; Wasterlid T; Spangberg LD; Rabbani L; Jylha C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hagglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;198(2):267-277
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients
Harrysson S; Eloranta S; Ekberg S; Enblad G; El-Galaly TC; Sander B; Sonnevi K; Andersson P-O; Jerkeman M; Smedby KE
Article: LEUKEMIA AND LYMPHOMA. 2022;63(6):1387-1397
Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia
Melen CM; Merrien M; Wasik AM; Panagiotidis G; Beck O; Sonnevi K; Junlen H-R; Christensson B; Sander B; Wahlin BE
Article: EJHAEM. 2021;2(4):774-784
Excellent survival after R-Hyper-CVAD in hospitalized patients with high-risk large B-cell lymphoma: The Karolinska experience
Sonnevi K; Ljungqvist M; Joelsson JK; Harrysson S; Wasterlid T; Bernell P; Wahlin BE
Article: BMC CANCER. 2021;21(1):500
The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome
Noring K; Carlsten M; Sonnevi K; Wahlin BE
Article: HEMASPHERE. 2021;5(1):e510
Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3
Eskelund CW; Dimopoulos K; Kolstad A; Glimelius I; Raty R; Gjerdrum LMR; Sonnevi K; Josefsson P; Nilsson-Ehle H; Bentzen HHN; Fagerli UM; Kuittinen O; Haaber J; Niemann CU; Pedersen LB; Larsen MT; Geisler CH; Hutchings M; Jerkeman M; Gronbaek K
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(1):75-81
Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study
Sonnevi K; Wasterlid T; Melen CM; Harrysson S; Smedby KE; Wahlin BE
Journal article: HEMATOLOGICAL ONCOLOGY. 2019;37(S2):572
THE CANNABINOID STUDY – 01: INVESTIGATING THE EFFECTS OF CANNABINOIDS IN INDOLENT LEUKEMIC B‐CELL LYMPHOMA
Melén CM; Merrien M; Wasik AM; Sonnevi K; Junlén H; Christensson B; Sander B; Wahlin BE
Journal article: HEMATOLOGICAL ONCOLOGY. 2019;37(S2):242
EARLY PROGRESSION OF MANTLE CELL LYMPHOMA DEPICTS A HIGH‐RISK DISEASE WITH POOR RESPONSE TO SUBSEQUENT THERAPIES AND A DISMAL OUTCOME
Eskelund CW; Kolstad A; Glimelius I; Räty R; Gjerdrum LR; Sonnevi K; Josefsson P; Nilsson‐Ehle H; Bentzen H; Fagerli U; Kuittinen O; Haaber J; Pedersen LB; Larsen MT; Geisler CH; Hutchings M; Jerkeman M; Grønbæk K
Article: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2019;8:7
The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994-2016
Carlsten M; Jadersten M; Hellstrom A; Littmann K; Melen CM; Junlen HR; Sonnevi K; Ljungman P; Bjorkstrand B; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(4):614-622
Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study
Melen CM; Enblad G; Sonnevi K; Junlen HR; Smedby KE; Jerkeman M; Wahlin BE
Article: THROMBOSIS RESEARCH. 2014;133(5):762-767
Risk factors for recurrent venous thromboembolism in young and middle-aged women
Ljungqvist M; Sonnevi K; Bergendal A; Holmstrom M; Kieler H; Larfars G
Article: THROMBOSIS RESEARCH. 2013;132(2):164-169
Self-reported family history in estimating the risk of hormone, surgery and cast related VTE in women
Sonnevi K; Bergendal A; Adami J; Larfars G; Kieler H
Article: BLOOD COAGULATION AND FIBRINOLYSIS. 2013;24(5):547-553
Obesity and thrombin-generation profiles in women with venous thromboembolism
Sonnevi K; Tchaikovski SN; Holmstrom M; Antovic JP; Bremme K; Rosing J; Larfars G
Article: THROMBOSIS AND HAEMOSTASIS. 2011;106(5):901-907
Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years
Sonnevi K; Tchaikovski SN; Holmstrom M; Rosing J; Bremme K; Larfars G
Journal article: BLOOD. 2010;116(21):154
High Thrombin Generation Measured In the Presence of Activated Protein C Is Associated with An Increased Risk of Recurrence Among Women 18–64 Years After a First Event of VTE
Sonnevi K; Tchaikovski SN; Bremme K; Holmstrom M; Rosing J; Larfars G
Visa fler

Alla övriga publikationer

Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(16)
EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL
Vose J; Vitolo U; Lugtenburg P; Chamuleau MED; Linton KM; Thieblemont C; Sonnevi K; Jurczak W; Olszewski AJ; Awan FT; Okada CY; Feldman TA; Hutchings M; Favaro E; Hoehn D; Li Z; Conlon R; Sancho J-M; Chavez JC
Letter: ACTA ONCOLOGICA. 2023;62(6):560-564
The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results
Smedby KE; Waesterlid T; Tham E; Haider Z; Joelsson J; Thorvaldsdottir B; Krstic A; Wahlin BE; Foroughi-Asl H; Karlsson C; Eloranta S; Saft L; Palma M; Kwiecinska A; Hansson L; Osterborg A; Wirta V; Rassidakis G; Sander B; Sonnevi K; Rosenquist R
Conference publication: BLOOD. 2022;140:10790
Rituximab Infusion in 30 Minutes' Is Safe and Improves the Flow of Outpatients with Lymphoma Treatment (SPEEDR)
Wahlin BE; Radman T; Ljungqvist M; Sonnevi K
Conference publication: BLOOD. 2021;138:4587
Good Outcome after R-Hyper-CVAD/R-MA in High-Risk Aggressive B-Cell Lymphoma: A Single-Center Experience
Sonnevi K; Ljungqvist M; Joelsson JK; Harrysson S; Wasterlid T; Bernell P; Wahlin B
Preprint: RESEARCH SQUARE. 2020
The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome
Noring K; Carlsten M; Sonnevi K; Wahlin B
Conference publication: BLOOD. 2020;136:3-4
Nationwide Investigation of Patient Trajectories in Mantle Cell Lymphoma - Initial Data from the Swedish MCL Complete Project
Jerkeman M; Palsdottir T; Glimelius I; Albertsson-Lindblad A; Weibull C; Ellin F; Sonnevi K; Lewerin C; Brandefors L; Smedby KE
Letter: ANNALS OF HEMATOLOGY. 2020;99(3):649-651
Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a unique BRAF mutation
Rassidakis GZ; Stromberg O; Xagoraris I; Jatta K; Sonnevi K
Conference publication: BLOOD. 2019;134:5487
A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma
Melen CM; Merrien M; Wasik A; Sonnevi K; Junlen H-R; Christersson B; Sander B; Wahlin BE
Conference publication: BLOOD. 2018;132:4121
Cannabinoid Receptors and CXCR4 Cross-Talk in Lymphoma Cells
Merrien M; Wasik AM; Melen C; Sonnevi K; Christensson B; Wahlin BE; Sander B
Preprint: SSRN ELECTRONIC JOURNAL. 2018
Morbidity, Mortality and Normality after Autologous Stem-Cell Transplantation for Lymphoma: A Comprehensive, Single-Centre, Population-Based, Real-World Analysis of Patients Transplanted 1994-2016
Carlsten M; Jädersten M; Hellström A; Littmann K; Melén CM; Junlén HR; Sonnevi K; Ljungman P; Björkstrand B; Wahlin B
Conference publication: HAEMATOLOGICA. 2014;99:537
MORTALITY AND CARDIOVASCULAR DISEASE AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM IN YOUNG AND MIDDLE-AGED WOMEN
Ljungqvist M; Sonnevi K; Odeberg J; Holmstrom M; Kieler H; Larfars G
Thesis / dissertation: 2013
Venous thromboembolism in women : risk factors and long term follow-up
Sonnevi, Kristina
Conference publication: BLOOD. 2012;120(21):2250
Obesity Is a Risk Factor for Recurrent Venous Thrombosis in Young and Middle-Aged Women. Results From Tehs-Follow up, a Nested Cohort Study On 1394 Women with VTE
Ljungqvist M; Sonnevi K; Bergendal A; Holmstrom M; Kieler H; Larfars G
Meeting abstract: THROMBOSIS RESEARCH. 2011;127:S140
High BMI is correlated to increased thrombin generation in women, age 18-65 after venous thromboembolism
Sonnevi K; Antovic J; Holmstrom M; Larfars G
Conference publication: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2011;9:632
Thrombin generation profiles and association with obesity and inflammation in women with VTE
Sonnevi K; Tchaikovski S; Holmstrom M; Bremme K; Rosing J; Larfars G
Conference publication: BLOOD. 2010;116(21):72
High Thrombin Generation Measured In the Presence of Activated Protein C Is Associated with An Increased Risk of Recurrence Among Women 18-64 Years After a First Event of VTE
Sonnevi K; Tchaikovski SN; Bremme K; Holmstrom M; Rosing J; Larfars G

Anställningar

Postdoktorala Studier, Medicin, Huddinge, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för klinisk forskning o utbildning, Södersjukhuset, Karolinska Institutet, 2013
Läkarexamen, Karolinska Institutet, 1999

Utvalda publikationer

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI